Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Maze Therapeutics (MAZE) Return on Sales (2024 - 2025)

Maze Therapeutics has reported Return on Sales over the past 2 years, most recently at 48.32% for Q2 2025.

  • Quarterly Return on Sales fell 5759.0% to 48.32% in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 48.32% through Jun 2025, changed N/A year-over-year, with the annual reading at 0.31% for FY2024, N/A changed from the prior year.
  • Return on Sales was 48.32% for Q2 2025 at Maze Therapeutics, down from 2.97% in the prior quarter.
  • Over five years, Return on Sales peaked at 9.27% in Q2 2024 and troughed at 48.32% in Q2 2025.